Earlyasset vs. EquityZen

Two approaches to the same problem

If you hold shares in a private company, you want to know what they're worth and whether you can access liquidity without waiting for an acquisition or IPO. Both Earlyasset and EquityZen address this need, but they use fundamentally different infrastructure.

EquityZen built a marketplace model - think of it as a bulletin board where shareholders list their shares and EquityZen works to find accredited investor buyers. Earlyasset built a direct buyer model - Earlyasset Capital acts as the counterparty to purchase qualifying positions directly from shareholders at predetermined prices based on company metrics and share class.

How EquityZen works

EquityZen operates as a marketplace platform for private company shares. Here's the typical flow:

• You list your shares on the platform (or request a listing)
• EquityZen solicits accredited investors and institutions looking to buy private shares
• Transactions are typically structured through special purpose vehicles (SPVs)
• EquityZen earns transaction fees from both buyers and sellers
• Shares remain listed until a buyer match is found - which can take weeks or months

The advantage of this model: it aggregates multiple buyers, so larger demand can potentially push prices higher. The disadvantage: your shares are publicly listed on the platform, and you're waiting for a buyer match rather than having immediate certainty of a sale.

How Earlyasset works

Earlyasset operates as a direct buyer platform. Earlyasset Capital evaluates your company and share class, then provides a price estimate directly. Here's the flow:

• You provide company information and your share details
• Earlyasset runs the company through its pricing algorithm (based on revenue, growth, margin, and valuation data)
• If your company qualifies and you hold a qualifying position, you get a price estimate immediately
• Your shares are never listed or exposed publicly
• If you proceed, Earlyasset Capital purchases your shares directly - no SPV, no broker fees

The advantage: speed, privacy, certainty of price. The disadvantage: you can only sell if your company meets Earlyasset's qualifying criteria (Series B+, $30M+ ARR in growth-stage companies).

Comparison table

When EquityZen makes sense

EquityZen is the right choice if:

• Your company is early-stage (pre-Series B or seed) and wouldn't qualify for Earlyasset's Law of 30
• Your position is smaller than Earlyasset's typical minimum
• You want to explore multiple buyer interest and potentially auction your shares
• You're willing to wait weeks or months for the right buyer match
• You prefer a marketplace where pricing is determined by live buyer demand

EquityZen has facilitated billions in private equity transactions and has a large base of accredited buyer interest. If your shares don't fit Earlyasset's criteria, EquityZen is a solid alternative.

When Earlyasset makes more sense

Earlyasset is the better fit if:

• Your company is Series B+ and meets the Earlyasset Law of 30 ($30M+ ARR, 50%+ growth, healthy margins)
• You want a price estimate immediately, with no listing or public exposure
• You value certainty over auction-like pricing - you want to know exactly what you'll receive
• Your company prefers a ROFR-compliant, streamlined secondary process
• You want to avoid broker fees and SPV complexity

Earlyasset's direct buyer model works best for shareholders in mature growth-stage companies where the secondary market is less crowded and pricing certainty matters more than competitive auction dynamics.

The key question

Are you a shareholder in a qualifying growth-stage company who wants immediate certainty of price and complete privacy, or are you willing to wait for a marketplace auction? That single question usually determines which platform makes the most sense for your situation.